ContractWarrant Agreement • November 14th, 2016 • Biolargo, Inc. • Chemicals & allied products • Nevada
THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BIOLARGO, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
BioLargo, Inc. FORM OF Convertible NoteConvertible Note • November 14th, 2016 • Biolargo, Inc. • Chemicals & allied products • California
FOR VALUE RECEIVED, BioLargo, Inc., a Delaware corporation (the "Company"), hereby promises to pay to the order of _______, or registered assigns (the "Holder”) the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the "Principal") when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest ("Interest") on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the "Issuance Date") until the same becomes due and payable, upon the Maturity Date or acceleration, conversion, redemption or otherwise (in each case in accordance with the terms hereof).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 14th, 2016 • Biolargo, Inc. • Chemicals & allied products • California
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of the 8th day of July, 2016 by and between BioLargo, Inc., a Delaware corporation (the “Company”), and the Investors listed on the signature page below (the “Investors”).
